Nine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600-1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results. © Springer-Verlag 2006.
|Titolo:||Gabapentin in the treatment of severe sweating experienced by advanced cancer patients|
|Autori interni:||RICEVUTO, Enrico|
|Data di pubblicazione:||2006|
|Rivista:||SUPPORTIVE CARE IN CANCER|
|Appare nelle tipologie:||1.1 Articolo in rivista|